Babak Negahdari (B Negahdari)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Silver Nanoparticles

Regulatory T Cells

Top Venues

BioMed research international

Future oncology (London, England)

Clinical and experimental immunology

Current pharmaceutical biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Hajar Abedi Joni, Fariba Esmaeili, Behnaz Landi, Elham Bayat, Haleh Bakhshandeh, Yeganeh Talebkhan, Farzaneh Barkhordari, Somayeh Sadeghi, Leila Nematollahi, Babak Negahdari
Formulation, Characterization, and Potential Therapeutic Implications of Encapsulated Recombinant Alpha-Luffin in Niosomes. Current pharmaceutical biotechnology (2024)
Hassan Valadbeigi, Saeed Khoshnood, Babak Negahdari, Mohd Azmuddin Abdullah, Mohammad-Hossein Haddadi
Antibacterial and Immunoregulatory Effects of Metformin against Helicobacter pylori Infection in Rat Model. BioMed research international 2023 (2023)
Hassan Valadbeigi, Saeed Khoshnood, Babak Negahdari, Mohd Azmuddin Abdullah, Mohammad-Hossein Haddadi
Antibacterial and Immunoregulatory Effects of Metformin against Helicobacter pylori Infection in Rat Model. BioMed research international 2023 (2023)
Nasser Hashemi Goradel, Arezoo Alizadeh, Shahnaz Hosseinzadeh, Mitra Taghipour, Zeinab Ghesmati, Arash Arashkia, Babak Negahdari
Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses. Future oncology (London, England) (2021)
Mohammad-Hossein Haddadi, Babak Negahdari, Ensiyeh Hajizadeh-Saffar, Mohsen Khosravi-Maharlooei, Mohsen Basiri, Hamed Dabiri, Hossein Baharvand
Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation-mediated instability using small molecules. Clinical and experimental immunology 201 (2) (2020)